Short-term outcome of pulmonary hemorrhage in very-low-birth-weight preterm infants.

[1]  Hsiang-Yu Lin,et al.  Pulmonary hemorrhage in very-low-birth-weight infants. , 2014, Pediatrics and neonatology.

[2]  A. Ohlsson,et al.  Surfactant for pulmonary haemorrhage in neonates. , 2012, The Cochrane database of systematic reviews.

[3]  M. Adhikari,et al.  Massive pulmonary haemorrhage as a cause of death in the neonate--a retrospective review. , 2004, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[4]  Turki M. Alkharfy.  High-frequency ventilation in the management of very-low-birth-weight infants with pulmonary hemorrhage. , 2004, American journal of perinatology.

[5]  網塚 貴介.  Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema , 2003 .

[6]  T. Wiswell.  Expanded uses of surfactant therapy. , 2001, Clinics in perinatology.

[7]  C. Peng,et al.  Risk factors of pulmonary hemorrhage in very-low-birth-weight infants: a two-year retrospective study. , 2000, Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi.

[8]  N. Subhedar,et al.  Pulmonary haemorrhage in preterm infants , 2000, European Journal of Pediatrics.

[9]  M. Kluckow,et al.  Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. , 2000, The Journal of pediatrics.

[10]  V. Bhandari,et al.  Pulmonary hemorrhage in neonates of early and late gestation , 1999, Journal of perinatal medicine.

[11]  S. Y. Ko,et al.  Massive pulmonary hemorrhage in newborn infants successfully treated with high frequency oscillatory ventilation. , 1998, Journal of Korean medical science.

[12]  K. Meert,et al.  Idiopathic pulmonary hemorrhage in infancy. Clinical features and management with high frequency ventilation. , 1996, Chest.

[13]  E. Kelly,et al.  Surfactant replacement in neonates with early chronic lung disease. , 1995, Pediatrics.

[14]  M. Dunn,et al.  Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. , 1995, Pediatrics.

[15]  F. Walther,et al.  Lysis of Red Blood Cells and Alveolar Epithelial Toxicity by Therapeutic Pulmonary Surfactants , 1995, Pediatric Research.

[16]  J. Garland,et al.  Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study. , 1994, Pediatrics.

[17]  L. Wright,et al.  A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. National Institute of Child Health and Human Development Neonatal Research Network. , 1993, The Journal of pediatrics.

[18]  P. Langenberg,et al.  Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. , 1993, The Journal of pediatrics.

[19]  B. Mitchell,et al.  Treatment Investigational New Drug experience with Survanta (beractant). , 1993, Pediatrics.

[20]  W Long,et al.  Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. , 1992, The Journal of pediatrics.

[21]  F. Walther,et al.  Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I. , 1992, The Journal of pediatrics.

[22]  R. Notter,et al.  Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. , 1987, Journal of applied physiology.